✦ LIBER ✦

Use of Calcium Antagonists in Patients with Ischemic Heart Disease and Systemic Hypertension

✍ Scribed by William H Frishman MD; M.Dror Michaelson MD; PhD

Book ID: 113978410
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 413 KB
Volume: 79
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(97)00270-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An Epidemiologic Perspective of Systemic

An Epidemiologic Perspective of Systemic Hypertension, Ischemic Heart Disease, and Heart Failure

✍ Peter W.F. Wilson MD 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Systemic oxidative stress status in pati

Systemic oxidative stress status in patients with ischemic heart disease

✍ A. Mezzetti; D. Lapenna; S.D. Pierdomenico; E. Porreca; A.M. Calafiore; G. Riari 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Factors influencing the responses to cal

Factors influencing the responses to calcium antagonists in elderly patients with hypertension and ischaemic heart disease

✍ R. Donnelly; H.L. Elliott 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 556 KB

Management of Hypertension in Patients W

Management of Hypertension in Patients With Ischemic Heart Disease: New Guidelines

✍ Ralph E. Watson 📂 Article 📅 2007 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 114 KB

Heart rate in hypertensive patients trea

Heart rate in hypertensive patients treated with ACE-inhibitors and calcium antagonists

✍ S.D. Pierdomenico; A. Bucci; F. Costantini; D. Lapenna; F. Cuccurullo; A. Mezzet 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

Systemic and coronary hemodynamics of la

Systemic and coronary hemodynamics of labetalol in normotensive patients with ischemic heart disease

✍ Robert L. Feldman; Xavier E. Prida; Charles R. Lambert; James A. Hill 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 536 KB

The systemic and coronary hemodynamic effects of combined alpha-and beta-adrenergic blockade produced by labetalol were assessed in 24 normotensive patients with angina pectoris and an ischemic electrocardiographic response to exercise stress. Beth the intravenous (0.5 mg/kg) and oral (200 mg) formu